Phase II Clinical Study on the Efficacy and Safety of QLS7305 in Patients With Kidney Disease (Part A)

Clinical trial NCT07730632 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07730632
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

IgAN - IgA Nephropathy Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)C3 Glomerulopathy (C3G)Primary Membranous Nephropathy

Start date: 2026-08-10
Primary completion: 2028-08-10
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.